Experienced in Chlamydia

Dr. Amneris E. Luque

Infectious Disease | Cardiology
5323 Harry Hines Blvd, 
Dallas, TX 
Experienced in Chlamydia
5323 Harry Hines Blvd, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Amneris Luque is an Infectious Disease specialist and a Cardiologist in Dallas, Texas. Dr. Luque is rated as an Experienced provider by MediFind in the treatment of Chlamydia. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Her clinical research consists of co-authoring 48 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Chlamydia.

Specialties
Infectious Disease
Cardiology
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

5323 Harry Hines Blvd, Dallas, TX 75390

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Implementation Research: Translating the ABCS Into HIV Care
Implementation Research: Translating the ABCS Into HIV Care
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Enrollment Status: Completed
Publish Date: August 03, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Enrollment Status: Completed
Publish Date: January 06, 2020
Intervention Type: Drug
Study Phase: Phase 2
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)
Enrollment Status: Completed
Publish Date: June 06, 2018
Intervention Type: Device, Drug
Study Phase: Phase 2
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
A Study to Evaluate Dolutegravir Plus Lamivudine Dual Therapy for the Treatment of Naïve HIV-1-infected Participants
Enrollment Status: Completed
Publish Date: May 09, 2018
Intervention Type: Drug
Study Phase: Phase 2
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Enrollment Status: Terminated
Publish Date: May 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

48 Total Publications

Choice of antiretroviral therapy has low impact on weight gain.
Choice of antiretroviral therapy has low impact on weight gain.
Journal: AIDS (London, England)
Published: June 04, 2024
Similar Doctors
Experienced in Chlamydia
Dr. Ank E. Nijhawan
Infectious Disease
Experienced in Chlamydia
Dr. Ank E. Nijhawan
Infectious Disease

University Of Texas Southwestern Medical Center At Dallas

5200 Harry Hines Blvd, 
Dallas, TX 
 (0.3 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances

Ank Nijhawan is an Infectious Disease provider in Dallas, Texas. Dr. Nijhawan is rated as a Distinguished provider by MediFind in the treatment of Chlamydia. Her top areas of expertise are HIV/AIDS, Kaposi Sarcoma, Myelitis, and AIDS Dysmorphic Syndrome.

Experienced in Chlamydia
Dr. Anusha G. Govind
Infectious Disease
Experienced in Chlamydia
Dr. Anusha G. Govind
Infectious Disease

University Of Texas Southwestern Medical Center At Dallas

5200 Harry Hines Blvd, 
Dallas, TX 
 (0.3 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances

Anusha Govind is an Infectious Disease provider in Dallas, Texas. Dr. Govind is rated as an Advanced provider by MediFind in the treatment of Chlamydia. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Luque's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile